Pharmacological strategies to enhance the response of hepatoblastoma to chemotherapy through MDR1 inhibition
{{output}}
Hepatoblastoma (HB) is the most common malignant liver tumor in children. One-fifth of patients exhibit a poor prognosis due to resistance to conventional chemotherapy, which typically includes doxorubicin. One of the underlying mechanisms is drug efflux throu... ...